144 related articles for article (PubMed ID: 8827774)
21. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.
Broxmeyer HE; Gentile P; Cooper S; Lu L; Juliano L; Piacibello W; Meyers PA; Cavanna F
Blood Cells; 1984; 10(2-3):397-426. PubMed ID: 6543656
[TBL] [Abstract][Full Text] [Related]
22. Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line.
Oquendo J; Dubanchet S; Capel F; Mabit H; Petit MA
Eur Cytokine Netw; 1996 Dec; 7(4):793-800. PubMed ID: 9010683
[TBL] [Abstract][Full Text] [Related]
23. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
24. Activities derived from established human myeloid cell lines reverse the suppression of cell line colony formation by lactoferrin and transferrin.
Broxmeyer HE; Rubin BY; Berman E; Juliano L; Lu L; Hast LJ; Cooper S; Singer JW
Exp Hematol; 1986 Jan; 14(1):51-9. PubMed ID: 3455916
[TBL] [Abstract][Full Text] [Related]
25. Lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines.
Zimecki M; Mazurier J; Spik G; Kapp JA
Arch Immunol Ther Exp (Warsz); 1996; 44(1):51-6. PubMed ID: 8874770
[TBL] [Abstract][Full Text] [Related]
26. Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages.
Boutten A; Dehoux M; Deschenes M; Rouzeau JD; Bories PN; Durand G
Eur J Immunol; 1992 Oct; 22(10):2687-95. PubMed ID: 1396973
[TBL] [Abstract][Full Text] [Related]
27. S-form lipopolysaccharide (LPS), but not lipid A or R-chemo-type LPS, induces interleukin-6 production in vitamin D3-differentiated THP-1 cells.
Suda Y; Aoyama K; Arimoto K; Tamura T; Kusumoto S
Biochem Biophys Res Commun; 1999 Apr; 257(2):327-32. PubMed ID: 10198211
[TBL] [Abstract][Full Text] [Related]
28. The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response.
van der Does AM; Bogaards SJ; Jonk L; Wulferink M; Velders MP; Nibbering PH
Biometals; 2010 Jun; 23(3):493-505. PubMed ID: 20238236
[TBL] [Abstract][Full Text] [Related]
29. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
Artym J; Zimecki M; Kruzel ML
Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
[TBL] [Abstract][Full Text] [Related]
31. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide.
Li JJ; Chen XJ
Coron Artery Dis; 2003 Jun; 14(4):329-34. PubMed ID: 12826933
[TBL] [Abstract][Full Text] [Related]
32. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.
Roy MK; Kuwabara Y; Hara K; Watanabe Y; Tamai Y
J Dairy Sci; 2002 Sep; 85(9):2065-74. PubMed ID: 12362437
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species.
Yoo YC; Watanabe R; Koike Y; Mitobe M; Shimazaki K; Watanabe S; Azuma I
Biochem Biophys Res Commun; 1997 Aug; 237(3):624-8. PubMed ID: 9299415
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
[TBL] [Abstract][Full Text] [Related]
35. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
[TBL] [Abstract][Full Text] [Related]
36. Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects.
Drago-Serrano ME; de la Garza-Amaya M; Luna JS; Campos-Rodríguez R
Int Immunopharmacol; 2012 Jan; 12(1):1-9. PubMed ID: 22101278
[TBL] [Abstract][Full Text] [Related]
37. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
38. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica.
León-Sicairos N; Reyes-López M; Ordaz-Pichardo C; de la Garza M
Biochem Cell Biol; 2006 Jun; 84(3):327-36. PubMed ID: 16936803
[TBL] [Abstract][Full Text] [Related]
39. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
[TBL] [Abstract][Full Text] [Related]
40. Release from mouse macrophages of acidic isoferritins that suppress hematopoietic progenitor cells is induced by purified L cell colony stimulating factor and suppressed by human lactoferrin.
Broxmeyer HE; Juliano L; Waheed A; Shadduck RK
J Immunol; 1985 Nov; 135(5):3224-31. PubMed ID: 3876380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
